Seonggyu Byeon

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Gas Chromatography

Tyrosine Kinase

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Cancer medicine

Investigative and clinical urology

This page only lists publications with an associated author ORCID identifier.

Publications

Seonggyu Byeon, Jaeyun Jung, Seung Tae Kim, Kyoung-Mee Kim, Jeeyun Lee
Clinical Implication of Concurrent Amplification of MET and FGFR2 in Metastatic Gastric Cancer. Biomedicines 11 (12) (2023)
Seonggyu Byeon, Jaeyun Jung, Seung Tae Kim, Kyoung-Mee Kim, Jeeyun Lee
Clinical Implication of Concurrent Amplification of MET and FGFR2 in Metastatic Gastric Cancer. Biomedicines 11 (12) (2023)
Song-Yi Lee, Seonggyu Byeon, Jihoon Ko, Sujin Hyung, In-Kyoung Lee, Noo Li Jeon, Jung Yong Hong, Seung Tae Kim, Se Hoon Park, Jeeyun Lee
Reducing tumor invasiveness by ramucirumab and TGF-β receptor kinase inhibitor in a diffuse-type gastric cancer patient-derived cell model. Cancer medicine 10 (20) (2021)
Seonggyu Byeon, Hyera Kim, Jinchul Kim, Minsuk Kwon, Joon Young Hur, Hwang Gyun Jeon, Seong Soo Jeon, Hyun Moo Lee, Se Hoon Park
Docetaxel rechallenge in metastatic castration-resistant prostate cancer: A retrospective, single-center study. Investigative and clinical urology 61 (6) (2020)
Seonggyu Byeon, Jang Ho Cho, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
PD-1 inhibitors for non-small cell lung cancer patients with special issues: Real-world evidence. Cancer medicine 9 (7) (2020)